MedTrace Logo

Effect of Early Memantine Administration on Outcome of Patients With Moderate to Severe Traumatic Brain Injury

NCT05531383 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2022-09-08

No results posted yet for this study

Summary

Effect of Early Memantine Administration on Outcome of Participents with Moderate to Severe Traumatic Brain Injury

Conditions

Interventions

DRUG

Memantine Hydrochloride

study the effect of memantine on platelet, platelet/lymphocyte ratio (PLR) and C reactive protein (CRP) \& serum NSE levels in patients with moderate to severe TBI as well as their outcome.

Sponsors & Collaborators

  • Minia University

    lead OTHER

Principal Investigators

  • Ibrahim Talaat, MD · Minia University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-26
Primary Completion
2023-11-20
Completion
2024-07-09

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05531383 on ClinicalTrials.gov